EMD 281014, a new selective serotonin 5-HT2A receptor antagonist
- PMID: 12892843
- DOI: 10.1016/s0014-2999(03)01992-7
EMD 281014, a new selective serotonin 5-HT2A receptor antagonist
Abstract
The 5-HT2A receptor ligand 7-[4-[2-(4-fluoro-phenyl)-ethyl]-piperazine-1-carbonyl]-1H-indole-3-carbonitrile HCl (EMD 281014) selectively binds to human (h) and rat 5-HT2A receptors (IC50 values 0.35 and 1 nM, respectively; vs. 1334 nM for h5-HT2C) and inhibited 5-HT-stimulated [35S]guanosine 5'-O-3-thiotriphosphate (GTPgammaS)-accumulation in h5-HT2A transfected Chinese hamster ovary cells (IC50 9.3 nM). EMD 28014 counteracted the N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ)-induced decrease of [3H]ketanserin binding in rat frontal cortex (ID50 0.4 mg/kg p.o.) and R-(-)-1-(2,5-dimethoxy-4-iodophenyl)-aminopropane (DOI)-induced head-twitch behaviour in mice (ID50 0.01 mg/kg s.c., 0.06 mg/kg p.o.), demonstrating unique selectivity and efficacy.
Similar articles
-
Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys.Psychopharmacology (Berl). 2005 Jun;179(4):725-32. doi: 10.1007/s00213-004-2114-1. Epub 2004 Dec 24. Psychopharmacology (Berl). 2005. PMID: 15619109
-
Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat.Eur J Pharmacol. 2006 Dec 28;553(1-3):163-70. doi: 10.1016/j.ejphar.2006.09.027. Epub 2006 Sep 23. Eur J Pharmacol. 2006. PMID: 17059817
-
(1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.J Pharmacol Exp Ther. 1995 Apr;273(1):101-12. J Pharmacol Exp Ther. 1995. PMID: 7714755
-
In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.J Neurosci Res. 2000 Sep 15;61(6):674-85. doi: 10.1002/1097-4547(20000915)61:6<674::AID-JNR11>3.0.CO;2-F. J Neurosci Res. 2000. PMID: 10972964
-
Serenics: an introduction.Drug Metabol Drug Interact. 1990;8(1-2):1-9. doi: 10.1515/dmdi.1990.8.1-2.1. Drug Metabol Drug Interact. 1990. PMID: 2091883 Review. No abstract available.
Cited by
-
Selective functionalization of the 1H-imidazo[1,2-b]pyrazole scaffold. A new potential non-classical isostere of indole and a precursor of push-pull dyes.Chem Sci. 2021 Aug 30;12(39):12993-13000. doi: 10.1039/d1sc04155j. eCollection 2021 Oct 13. Chem Sci. 2021. PMID: 34745530 Free PMC article.
-
Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset.Pharmacol Rep. 2022 Aug;74(4):614-625. doi: 10.1007/s43440-022-00378-9. Epub 2022 Jun 27. Pharmacol Rep. 2022. PMID: 35761013
-
A spinal mechanism of action for duloxetine in a rat model of painful diabetic neuropathy.Br J Pharmacol. 2011 Sep;164(1):159-69. doi: 10.1111/j.1476-5381.2011.01334.x. Br J Pharmacol. 2011. PMID: 21410686 Free PMC article.
-
Neurophysiological Treatment Effects of Mesdopetam, Pimavanserin and Amantadine in a Rodent Model of Levodopa-Induced Dyskinesia.Eur J Neurosci. 2025 Mar;61(5):e70032. doi: 10.1111/ejn.70032. Eur J Neurosci. 2025. PMID: 40042199 Free PMC article.
-
Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys.Psychopharmacology (Berl). 2005 Jun;179(4):725-32. doi: 10.1007/s00213-004-2114-1. Epub 2004 Dec 24. Psychopharmacology (Berl). 2005. PMID: 15619109
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources